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Introduction: During pulpectomy of primary teeth, cytotoxic medicaments such as formocresol 
or camphor mono-chlorophenol (CMCP) are used as medicaments. For the first time it is theorized 
that chitosan can substitute these traditional materials used in pulpectomy of infectious primary 
teeth. Methods and Materials: This preliminary in vitro study consisted of two separate phases 
(n=75), each of which assessed the antibacterial effects of chitosan versus formocresol and CMCP 
and positive/negative controls (n=15) on three bacteria types [Enterococcus faecalis, Staphylococcus 
aureus, Streptococcus mutans, (n=5 per subgroup)]. Phases 1 and 2 concerned respectively with 1- 
and 7-day effects of these materials. Bacteria were cultured and injected into sterilized canals and 
colonies were counted. Medicaments were applied and colonies were re-counted after 1 day of 
treatment (phase 1). Specimens were re-sterilized and re-randomized, and used for phase 2, in 
which the same procedures were performed for a 7-day period. Effects of agents on bacteria were 
analyzed statistically (Kruskal-Wallis α=0.05 and Mann-Whitney α=0.017). Results: Treatments 
reduced bacterial count either after 1 or 7 days (P=0.000). Their effects on different bacteria types 
were not significant either after 1 or 7 days (P>0.48). Antibacterial efficacies of treatments 
(indicated by colony reduction) were significantly different, after 7 days (P=0.045). Antibacterial 
efficacy of chitosan was similar to that of formocresol or CMCP, in both phases [either after 1 or 
7 days of treatment (P>0.017). Formocresol and CMCP had similar efficacies in either phase 
(P>0.017). Conclusions: This preliminary study confirmed the appropriate antibacterial efficacy of 
chitosan as a medicament in pulpectomy of infectious primary teeth. 
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Introduction 
he purpose of root canal treatments (including pulpectomy 
in primary dentition) is to remove bacteria and their 
products as well as contaminated tissues from the canal through 
mechanical and chemical cleansing and debridement [1, 2]. 
Mechanical preparation accounts for about only half of the 
reduction in the number of bacteria. Because of anatomical 
variations and complex morphology of canals, isthmuses, apical 
accessory canals and incomplete root canal connections, these 
variations and anatomical limitations are more pronounced in 
primary teeth, especially in primary molars [3, 4]. Therefore, it 
is recommended to use chemical methods and antimicrobial 
agents that can access such anatomical variations and reduce 
microorganisms more effectively [5].  
Due to the possibility of microorganisms’ survival after 
mechanical and chemical canal preparation and cleaning, the use of 
medicaments or antimicrobial dressings is recommended between 
T
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sessions in order to reduce bacteria as well as pain and swelling after 
treatment [6]. Such agents should possess desirable antimicrobial 
effects [2, 7]. Although various agents have been proposed for this 
purpose, none of them have shown considerable superiority over 
the others [8]. Formocresol and camphor mono-chlorophenol 
(CMCP) have high antimicrobial activity [9-11]. However, the use 
of formocresol which is the most common used material and also 
the golden standard for medicament is controversial due to its 
potential cytotoxicity [12-16]. It has been associated with 
carcinogenicity, immunological changes, cytotoxicity, 
teratogenicity, mutagenic effects and causing enamel defects in 
permanent teeth and systemic changes in internal organs such as 
the kidneys and the liver [11-13, 15-19]. CMCP is also a phenolic 
derivative that can stimulate periapical tissues at higher 
concentrations. Therefore, an alternative material with high 
efficacies would be of utmost clinical interest. 
Local and systemic distribution of medicaments [20] calls 
for seeking safer and yet adequately effective agents. A new 
material recently proposed for root canal therapy is chitosan, 
which is an appropriate antimicrobial agent, with anti-
inflammatory properties, proper biocompatibility, and does 
not cause irritation [21-23]. Chitosan is a cationic 
polysaccharide derived from chitin (a major component of 
crustaceans) which has attracted great attention due to its 
excellent biocompatibility and non-toxicity [23-30]. Its 
positive charge facilitates its attachment to surfaces with 
negative charge and exert its anti-bacterial and anti-fungal 
properties, through binding to the negatively charged bacterial 
and increasing its permeability [31]. Besides being effective 
against a wide range of microorganisms, chitosan also 
possesses anti-inflammatory effects and facilitates tissue 
regeneration, and also can enhance the anti-erosive/anti-
abrasive effects of the Sn2+ [32-37]. Chitosan has been used in 
different forms including gums, dentifrices, toothpastes, etc, 
and has shown to be effective in reducing enamel 
decalcification and caries as a result of reduced bacterial 
activity [24, 38-40] and inhibiting the release of mineral 
elements [41]. In terms of intracanal agents, few studies have 
evaluated effects of chitosan on microorganisms, and have 
found promising results compared to traditional canal 
irrigating medicaments such as sodium hypochlorite [42-45].  
However, such concentrations were not optimized for 
primary root canal therapy, and no studies have assessed the 
efficacy of chitosan as a “medicament” for root canal treatment 
of infectious primary teeth (i.e. pulpectomy). Therefore, this 
two-phase study aimed to assess comparatively the efficacy of 
a new concentration of chitosan optimized for pulpectomy 
dressing in comparison with the most effective materials in the 
field (Formocresol and CMCP). 
Materials and Methods 
This in vitro experimental study was performed in two phases (each 
with its independent data) on 150 observations from 75 primary 
canines (65 maxillary and 10 mandibular) extracted for clinical 
purposes. The first phase concerned with the bacterial growth over 
a 24 h period, while the second phase was about bacterial growth 
over a one-week period. Each of these phases had its own baseline 
colony counts, to be compared with the colony counts after either 1 
or 7 days. The inclusion criteria were intact roots or health of more 
than 3/4 of the root. The exclusion criteria were fractures or external 
resorptions on the root. 
The teeth were first debrided and stored in 0.9% normal saline 
+ 0.1% sodium hypochlorite for 6 h, and then washed and stored in 
0.9% normal saline until the examination day. The teeth were cut 
using paper discs from the cementoenamel junction (CEJ) [46] in 
order to exclude the coronal length and bur preparation variables as 
well as for a better access to the root canals for medicament 
placement. A K-file #15 (Mani, Tochigi, Japan) was used to ensure 
the patency of canals. The working length was then estimated by 
subtracting 1 mm from the length of the K-file in a tip-to-tip 
position. The canals were cleaned and prepared to the #40 K-file 
(Mani, Tochigi, Japan) while being irrigated between filing sessions, 
with 2 mL of normal saline. 
Producing chitosan 
An experimental concentration of chitosan solution was 
determined as 1.5% through discussion of experts in pediatric 
dentistry. It was produced by blending chitosan (ChitoClear, 
Primex, Siglufjordur, Iceland) with 1% acetic acid (Merck, 
Darmstadt, Germany).  
Phase 1: 24h effects 
Grouping 
The teeth were randomly divided into 15 subgroups of 5 each, 
according to the following descriptions: 
Group 1 (n=25): Enterococcus faecalis (ATCC 29212) was 
applied to this group, which would consist of 5 subgroups (1A to 
1E). Group 2 (n=25): Staphylococcus aureus (ATCC 29213) would 
be applied to this group, which consisted of 5 subgroups (2A to 2E). 
Group 3 (n=25): Streptococcus mutans (PTCC 1683) would be 
applied to this group (3A to 3E subgroups). 
Group A (n=15): comprised roots that would be filled with 
bacteria (three subgroups of 5 each corresponding to the groups 1, 2, 
and 3 [i.e., 1A, 2A, 3A]) but were not subjected to antimicrobial 
treatments. Group B (negative control) (n=15): consisted of sterilized 
roots which were not subjected to bacterial addition or antimicrobial 
application. This group was used to assess the efficacy of sterilization 
and aseptic protocols, during the study (102). Group C (chitosan, 
n=15): this group would include roots filled with three different 
bacteria (n=3) and later filled with chitosan, as a potential 
antimicrobial agent. Groups D (formocresol, PD, Switzerland), 
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(n=15): the same as group C but with formocresol for the 
antimicrobial agent. Group E (CMCP, PD, Switzerland), (n=15): 
similar to groups C and D, but with CMCP as the antibacterial agent.  
Mounting the roots in containers 
Before being mounted in acrylic resin, the apices were sealed using 
light-cured glass ionomer (Fuji II LC, GC Corporation, Tokyo, 
Japan), to prevent leakage of acrylic resin into the canal. The roots 
of each subgroup (n=5) were mounted upright by their apices on a 
glass plate filled with 5 mm of transparent acrylic resin (Meliodent, 
UK). Therefore, there were 15 plates for the 15 subgroups. 
Sterilization the roots before the examination 
The plates were autoclaved for 15 min at 121°C and a 15 Pascal 
pressure. 
Microbial suspension 
Standard strains of bacteria used include Streptococcus mutans 
(PTCC 1683), Enterococcus faecalis (ATCC 29212), Staphylococcus 
aureus (ATCC 29213), were purchased from the Center for 
Collection of Fungi and Bacteria as a collection of lyophilized vials 
[47]. To prepare the bacterial suspension and induce the viability of 
the bacteria, 2 cc of sterile liquid medium (Brain Hearth Infusion 
(BHI) Broth) (Merck, Darmstadt, Germany) was added into the 
lyophilized vials and mixed completely, so that the powder was 
completely solved and a homogenous suspension produced. A 
sterilized loop was used to obtain a drop of the above suspension 
and culture it on a blood agar medium (Merck, Darmstadt, 
Germany). Finally, the plates were stored at 37°C for 48 h. S. mutans 
plates were stored at 37°C in 5-10% CO2. The bacteria were cultured 
in BHI Broth to achieve a sufficient volume of 0.5-McFarland 
(1.5×108 CFU/mL) concentration. 
Injection of bacterial suspension into the root canals 
Except for subgroups B (negative control), each root in other 
subgroups was injected with 10 µL of bacterial suspension within 
BHI Broth. In the negative control group, BHI Broth alone was 
injected.  
Incubation 
Plates were incubated for 72 h at 37°C. In order to prevent root 
dehydration, 10 cc distilled water was added to each plate. As 
bacterial nutrition, 10 μL of BHI-Broth medium was added daily to 
each of the roots.  
Baseline colony count 
After removing the specimens from the incubator, a #25 K-file was 
drawn to the canal wall to accumulate debris. Then, 20 microliters 
of BHI-Broth medium were placed the roots using specific 
samplers. After ensuring the release of bacteria, 10 μL of canal 
content was extracted using the sampler and transferred to 990 μL 
of BHI-Broth medium, in order to produce an initial concentration 
of 1:100. Owing to the high number of colonies, the content was 
again diluted 1:10000. Using a standard loop, 0.01 mL was collected 
from the suspension and transferred to the solid BHI agar medium. 
Plates containing these media (except those containing S. mutans) 
were then incubated at 37°C for 24-48 h. S. mutans plates were 
cultured on blood agar, at 37°C and 5-10% CO2 for 24 to 48 h. 
Afterwards, the colonies were counted with the naked eye, and 
the number of viable bacteria was estimated according to the 
following formula: colony-forming unit (CFU)/mL=colony count 
× suspension dilution (10000) × loop coefficient (100). 
Application of antimicrobial agents 
In the next step, a cotton wool was impregnated with 20 μL of 
antimicrobial agents including formocresol (PD, Swiss), CMCP (PD, 
Swiss), and chitosan 1.5% (Chitoclear, Island). They were placed in 
the canal orifices. Then the canal was sealed using and the orifice of 
the canal was sealed with a dressing (Zonalin, Kemdent, UK). 
Incubation 
The roots were incubated (as mentioned earlier) for 24 h.  
Colony count after 1 day of incubation 
After removing the dressing with a dental excavator, the colonies 
were counted as explained earlier, with the only difference that the 
bacteria-incorporated BHI Broth was diluted to 1:100 only. 
Afterwards, a standard loop was used to pick 0.01 μL of the 
suspension and culture it on BHI agar and blood agar for 24 to 48 h 
at 37°C. The colonies were counted as CFU/mL =colony count × 
suspension dilution (100) × loop coefficient (100). 
Phase 2: one-week effects 
The 7-day effects of materials were not tested in the same sample, 
because the assessment of bacterial count in the first day could 
confound the results pertaining to the 7-day examination. 
Therefore, we re-performed the whole study to estimate the 7-day 
effect of the materials. For this purpose, all of the plates of teeth were 
randomized and sterilized again and used for procedures which 
were identical to the phase 1, with the only difference that there 
were 7 days of incubation after the placement of antibacterial agents 
(instead of 1 day). All the other procedures were identical to the 
phase 1. During the period of treatment (either the 1-day treatment 
in phase 1 or the 7-day treatment in phase 2), the canals were not 
injected with culture medium, as they were sealed for treatment 
purposes. The two phases did not share the same baseline colony 
counts, as they were two different studies. The negative control 
specimens in this phase were as well all clear of any bacteria.  
Calculation the percentage of reduction in colony count (%RCC) 
For each of the two phases, the colony count after the placement of 
antimicrobial agent (either after 1 day in phase 1 or after 7 days in 
phase 2) was subtracted from the baseline colony count in that 
phase, in order to calculate the delta-count. A positive delta-count 
value would indicate a reduction in bacterial numbers, while a 
negative delta-count value meant bacterial growth. The delta-count 
was divided by the baseline count to calculate the %RCC. 
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Statistical analysis 
The negative control confirmed the complete aseptic conditions 
(as no bacterial growth in any negative controls), in both phases. 
Since the two phases did not share the same baseline and 1-day 
colony counts and since the roots had been randomized before 
phase 2, we did not merge the data obtained from both phases. 
Instead we analyzed each phase separately, as an independent 
study. In each phase, means and medians were calculated for 
each material, before and after the treatment. Comparisons were 
performed using the Kruskal-Wallis, Mann-Whintey U and 
Wilcoxon tests with SPSS 25 (IBM, Armonk, NY, USA) within 
each phase and between the short-term (in phase 1, after 1 day 
of treatment) versus long term exposures (in phase 2, after 7 days 
of treatment). Level of significance was predetermined as 0.05 
for all tests except post-hoc Mann-Whitney U tests which had 
levels of significance equal to 0.017.  
 
Table 1. Descriptive statistics for pre- and post-treatment colony counts, delta colony counts, and percent of colony counts (%RCC) in each 
subgroup of phase 1, and the results of the Kruskal-Wallis test  
  Chitosan Formocresol CMCP Control 
P-value 
Bacteria Parameter Mean (SD) Mean (SD)  Mean (SD) Mean (Median) 
Enterococcus 
Pre treatment 11×10 6 (10×10 6) 484×10 5 (610×10 5) 232×10 5 (250×10 5) 388×10 5 (190×10 5) 0.116 
Post treatment 306×10 3 (100×10 3) 0 (0) 0 (0) 436×10 5 (230×10 5) 0.007 
Delta-Colony 10694×10 3 (9900×10 3) 484×10 5 (610×10 5) 232×10 5 (250×10 5) -48×10 5 (-40×10 5) 0.093 
%RCC 98 (99) 100 (100) 100 (100) -19 (-16) 0.011 
Staphylococcus 
Pre treatment 194×10 6 (170×10 6) 25×10 7 (25×10 7) 228×10 6 (240×10 6)  25×10 7 (25×10 7)  0.300 
Post treatment 4926×10 3 (6000×10 3) 330 (0) 0 (0) 257×10 6 (260×10 7)  0.003 
Delta-Colony 189074×10 3 (162000×10 3) 249999670 (25×10 7)  228×10 6 (240×10 6)  -12×10 6 (-10×10 6) 0.184 
%RCC 97 (96) 100 (100) 100 (100) -380 (-5) 0.003 
Streptococcus 
Pre treatment 44400 (42000) 74360 (10×10 4) 57360 (65×10 3) 5×10 4 (5×10 4) 0.296 
Post treatment 40 (0) 0 (0) 0 (0) 52600 (55000) 0.116 
Delta-Colony 44360 (42000) 74360 (10×10 4) 57360 (65×10 3) -2600 (-2000) 0.296 
%RCC 100 (100) 100 (100) 100 (100) -6 (-4) 0.117 
 
Table 2. Descriptive statistics for pre- and post-treatment colony counts, delta colony counts, and percent of colony counts (%RCC) in each 
subgroup of phase 2, and the results of the Kruskal-Wallis test 
  Chitosan Formocresol CMCP Control 
P-value 
Bacteria Parameter Mean (SD) Mean (SD) Mean (SD) Mean (Median)  
Enterococcus 
Pre treatment 264×10 6 (200×10 6)  248×10 5 (210×10 5) 142×10 5 (100×10 5) 372×10 5 (200×10 5) 0.008 
Post treatment 31×10 4 (30×10 4) 0 (0) 0 (0) 34×10 6 (19×10 6) 0.007 
Delta-Colony 26369×10 4 (19970×10 4)  248×10 5 (210×10 5)  142×10 5 (100×10 5)  32×10 5 (20×10 5)  0.008 
%RCC 100 (100)  100 (100)  100 (100) 11 (8)  0.007 
Staphylococcus 
Pre treatment 1728×10 5 (1400×10 5)  1088×10 5 (700×10 5)  42×10 5 (20×10 5)  3×10 8 (3×10 8)  0.007 
Post treatment 1196×10 3 (900×10 3)  0 (0)  0 (0)  272×10 6 (270×10 6)  0.007 
Delta-Colony 171604×10 3 (139870×10 3)  1088×10 5 (700×10 5)  42×10 5 (20×10 5)  28×10 6 (30×10 6)  0.327 
%RCC 99 (100)  100 (100) 100 (100)  9 (10)  0.000 
Streptococcus 
Pre treatment 13×10 4 (3×10 4)  10×10 4 (10×10 4)  58×10 3 (65×10 3)  48×10 3 (50×10 3)  0.042 
Post treatment 0 (0) 0 (0) 0 (0) 44×10 3 (47×10 3)  1.000 
Delta-Colony 13×10 4 (3×10 4)  10×10 4 (10×10 4)  58×10 3 (65×10 3)  40×10 2 (30×10 2)  0.042 
%RCC 100 (100)  100 (100)  100 (100)  9 (10)  1.000 
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Results 
Except few subgroups which showed an increase in colony count, 
all other subgroups showed reductions in colony count in either 
phase. The Kruskal-Wallis test showed significant differences 
among treatments, in many of subgroups’ pre- and post-
treatment colony counts as well as delta-counts and %RCCs 
(Tables 1 and 2). 
Phase 1 
In phase 1, Wilcoxon test showed a significant effect on colony 
counts (P=0.000, positive mean rank for comparison=20.17, 
negative mean rank=33.35) (Figure 1). The Kruskal-Wallis test did 
not show a significant difference between %RCC values of different 
bacteria types (P=0.485, mean ranks for bacteria: 
Enterococcus faecalis=28.89, Staphylococcus aureos=27.65, 
Streptococcus mutans=33.40). The Kruskal-Wallis test indicated a 
significant difference between %RCC values of treatment types 
(P=0.000, mean ranks for treatments: Chitosan=12.13, 
Formocresol=26.80, CMCP=29.00). According to the Mann-
Whitney U test, difference between chitosan and formocresol was 
significant with chitosan showing a smaller reduction (P=0.001, 
mean ranks for treatments: Chitosan=10.27, Formocresol=20.73); 
difference between chitosan and CMCP was significant as well 
again with chitosan showing a smaller reduction (P=0.000, mean 
ranks: Chitosan=9.87, CMCP=20.50); however, there was not a 
significant difference between formocresol and CMCP (P=0.561, 
mean ranks: Formocresol=14.07, CMCP=16.00). 
Comparing delta-colony values (changes in colony counts over 
time), Kruskal-Wallis test did not show a significant difference 
between delta-colony counts among treatment types (P=0.548).  
 
Phase 2 
In phase 2, Wilcoxon test showed a significant effect on colony 
counts in 7 days (P=0.000, positive mean rank for 
comparison=0.00, negative mean rank=30.50) (Figure 1). The 
Kruskal-Wallis test did not show a significant difference 
between %RCC values of different bacteria types (P=0.581, 
mean ranks for bacteria: Enterococcus faecalis=29.25, 
Staphylococcus aureos=28.85, Streptococcus mutans=33.40). 
The Kruskal-Wallis test showed a significant difference 
between %RCC values of different treatment types (P=0.000, 
mean ranks for treatments: Chitosan=15.00, 
Formocresol=27.00, CMCP=27.00). According to the Mann-
Whitney U test chitosan acted weaker than other two, 
difference between chitosan and formocresol was significant 
(P=0.011, mean ranks for treatments: Chitosan=11.50, 
Formocresol=19.50); difference between chitosan and CMCP 
was significant as well (P=0.011, mean ranks: Chitosan=11.50, 
CMCP=19.50); however, there was not a significant difference 
between formocresol and CMCP (P=1.0, mean ranks: 
Formocresol=15.00, CMCP=15.00).  
Comparing delta-colony counts, the Kruskal-Wallis test 
indicated a significant difference between delta-colony values 
of treatment types (P=0.045, mean ranks for treatments: 
Chitosan=28.20, Formocresol=24.30, CMCP=16.50). 
According to the Mann-Whitney U test, difference between 
chitosan and formocresol was not significant (P=0.233); 
difference between chitosan and CMCP was marginally 
significant, with chitosan showing a greater reduction 
(P=0.041, mean ranks: Chitosan=18.77, CMCP=12.23); and 
there was a marginally significant difference between 
formocresol and CMCP (P=0.045, mean ranks:  
Formocresol=18.73, CMCP=12.27).  
Table 3. Asymptotic P-values calculated using Mann-Whitney U test between both phases 
Bacteria Pretreatment Colony Count Post treatment Colony Count Delta Colony Count %RCC 
Enterococcus faecalis 
Chitosan 0.009 0.834 0.009 0.094 
Formocresol 0.175 1.000 0.175 1.000 
CMCP 0.600 1.000 0.600 1.000 
Control 1.000 0.347 0.009 0.009 
Staphylococcus aureos 
Chitosan 0.458 0.175 0.465 0.173 
Formocresol 0.035 0.136 0.036 0.136 
CMCP 0.009 1.000 0.009 1.000 
Control 0.228 0.674 0.009 0.009 
Streptococcus mutans 
Chitosan 0.915 0.134 1.000 0.136 
Formocresol 0.521 1.000 0.521 1.000 
CMCP 0.916 1.000 0.916 1.000 
Control 1.000 0.602 0.009 0.008 
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Figure 1. Colony counts in the pre- and post-treatment sessions, in phases 1 (left) and 2 (right) 
 
Comparisons between short-term and long-term exposures 
(phases 1 and 2) 
Differences between the %RCC and delta-count values of phase 1 
versus phase 2 were observed in few cases only (Table 3). When all 
bacteria subgroups were aggregated, pre-treatment values were not 
different in phase 1 versus phase 2, in any of the 4 treatment groups 
(all 4 Mann-Whitney P-values>0.2). The same held for post-
treatment colony counts (all 4 Mann-Whitney P-values>0.4). 
When comparing the delta-colony counts of each treatment 
between two phases (when all bacteria groups were aggregated), 
only the control group showed a significant difference between the 
two phases (P=0.000) while the other groups [CMCP, formocresol 
and chitosan] did not have a significant difference between the 
short-term and long-term phases (P>0.2). When comparing the 
%RCC values between the short- and long-term phases, only the 
control group showed a significant difference (P=0.000). CMCP, 
formocresol and chitosan did not have different %RCC values 
between two phases (P>0.07). 
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Discussion 
Findings of this study indicated that compared with the 
control, all three medicaments were effective in reducing 
bacterial count, either after 1 day or 7 days of treatment. 
Chitosan was as effective as formocresol and CMCP in short 
term, but was slightly more effective than CMCP, in 7 days 
period. Formocresol and CMCP acted similarily  in short and 
long terms (although formocresol was slightly better than 
CMCP in 7 days). The 1-day and 7-day effects of the agents on 
various bacteria were not different except for few agents in the 
case of some bacteria. The control group showed a slight 
increase in bacterial count after 1 day; however, in phase 2, 
controls showed a slight reduction in bacterial count, which 
might be due to sealing of canals and lack of nutritional 
materials necessary for bacterial growth. However, this is not the 
case in clinical situations where sufficient nutrition is provided. 
Comparison of both phases showed differences between the 
colonies counted in the first and seventh days, only in the case 
of control group. This might be due to the post-treatment colony 
counts being close to zero in both phases (either after 1 day or 
after 7 days).  
Our results in terms of the efficacy of chitosan -being 
comparable to that of CMCP and formocresol in 1 or 7 days- 
can suggest promising results for this experimentally produced 
concentration of chitosan. Studies on other uses of chitosan as 
well found it successful. Moghadas et al. [42] reported similar 
antimicrobial effects of nano-chitosan and sodium 
hypochlorite (used as canal irrigators) on Staphylococcus 
aureus and Enterococcus faecalis [42]. Also Suzuki et al. [43] 
confirmed the antibacterial effects of chitosan solution against 
Enterococcus faecalis. Hayashi et al. [39] examined 
antibacterial effects of chitosan-incorporated chewing gum, 
and observed reduced amounts of bacteria compared to their 
control group who had used a mouth rinse. Jaiswal et al. [44] 
comparatively assessed the efficacy of chitosan as a canal 
irrigation solution against Enterococcus faecalis and concluded 
that Chitosan + Chlorhexidine, Chlorhexidine and Propolis 
can be as efficacious as sodium hypochlorite. Camacho-Alonso 
et al. [45] examined the antibacterial efficacy of photodynamic 
therapy and chitosan against Enterococcus faecalis in 
experimentally infected root canals and reported that 
combination of PDT and chitosan can be effective. 
Uysal et al [38] evaluated the effect of chitosan dentifrice 
on enamel decalcification around orthodontic brackets, and 
reported that the chitosan mouthwash was able to reduce 
decalcification in patients with poor oral hygiene. Another 
study on chitosan-containing mouthwashes was performed by 
Costa et al. [48] who observed superior results of chitosan 
mouthwash compared with two commercial mouth rinses. 
Mirhashemi et al. [49] added chitosan nanoparticles to 
composite bracket-bonding agents and verified its 
antibacterial effect. Targino et al. [24] assessed the 
antimicrobial effects and biocompatibility of a formulation 
containing silver nanoparticles, chitosan, and fluoride; and 
concluded that this formula is a promising anti-caries agent 
with proper antimicrobial effects, low toxicity to living cells, 
and not staining teeth black [24].   
Since there was no study on the efficacy of chitosan as a 
medicament in infectious primary teeth, we are limited to 
discussing results pertaining to more general aspects of this 
study. The findings of this study in terms of similar efficacies 
of CMCP and formocresol were similar to the study of Rosa et 
al. [9] who reported these two materials as similarly the best 
ones among others including chlorhexidine and calcium 
hydroxide. Menezes et al. [10] as well reported Ca(OH)2 + 
CPMC paste as the most effective intracanal drug for the 
elimination of the two microorganisms Candida albicans and 
Enterococcus faecalis. Ferreira et al. [50] as well did not observe 
any significant difference between the antimicrobial effects of 
formocresol and CMCP, which again was similar to the present 
study. In the study of Meshki et al. [8], antimicrobial effects of 
formocresol, CMCP, sodium hypochlorite and 0.2% 
chlorhexidine were compared. According to them, 
formocresol and CMCP were superior to the other two. In 
another study, among formocresol, 2% glutaraldehyde and 
iodine-potassium, formocresol and glutaraldehyde showed the 
highest antimicrobial activity [51].  
This pilot study was limited by some factors. Although the 
sample size was adequate to draw numerous significant results, 
it should have been determined based on pilot studies. Another 
limitation was that we could not technically sample from the 
same canals both in the first and seventh days; therefore, we 
had to either limit the study to one phase only or repeat the 
study in two phases. This was advantageous, as the accuracy of 
many of the practices (such as the negative and positive 
controls, or the pre-treatment colony counts) were verified by 
being conducted twice in separate studies (phases). Still, future 
studies should evaluate longer periods. We checked a 1-week 
period because it was relevant to the clinical situations, when 
there is a 1-week interval between the two sessions. Also future 
studies should evaluate various concentrations of chitosan in 
terms of optimum antibacterial efficacy and biocompatibility, 
even though chitosan is already known as a biocompatible 
material for other uses [21, 22]. Since results of in vitro studies 
cannot be generalized to clinical situations, future animal and 
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human studies are needed to verify the current study. As an 
advantage, we used three different bacteria which are mostly 
held responsible for recurrent root canal infections. Finally, 
since pulpectomy as well needs antibacterial dressings [52], 
chitosan can be a proper alternative; therefore, future studies 
should assess the antibacterial efficacy and biocompatibility of 
this material as a pulpectomy dressing. 
Conclusion 
This preliminary study confirmed for the first time the 
appropriate efficacy of chitosan as a medicament for 
pulpectomy. Both phases indicated a decrease in colony counts 
over time. After 24 h of treatment, the antibacterial effect of 
chitosan might be comparable to or better than formocresol 
and CMCP, all being superior to the effect of positive control 
which might not show a decrease. After 7 days of treatment as 
well, chitosan might act similar to CMCP and formocresol, 
both of which were significantly effective compared to the 
control. 
Conflict of Interest: ‘None declared’. 
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